First company to enable precision in vivo genome engineering, combining both cell-specific delivery and programmable, locus-specific gene insertion, with the potential to achieve physiological, durabl ...

Following the relaunch, ZEUSx DEX recorded over $1 billion in swap volume, driving the Total Value Locked (TVL) across the ...